Dexcom | DXCM - Stock

Aktienkurs
58.11
Täglich Wechseln
-1.19 -2.01%
Monatlich
-6.12%
Jährlich
-18.59%
Q2 Prognose
60.25




Stock Veränderung Datum
Abbott USD 6.49B 220M 2025-12
Align Technology USD 228.16M 15.59M 2025-09
AtriCure USD 78.49M 459K 2025-12
Avanos Medical USD 148M 2.6M 2025-12
Baxter International USD 2.23B 228M 2025-12
Becton, Dickinson and Co. USD 4.08B 191M 2025-12
Boston Scientific USD 2.94B 22M 2025-12
Cooper Companies USD 846M 35M 2025-09
Dexcom USD 629.1M 25M 2025-12
Edwards Lifesciences USD 1.13B 14.7M 2025-12
Globus Medical USD 759.28M 12.26M 2025-12
Inogen USD 25.08M 762K 2025-09
Insulet USD 452.6M 6.3M 2025-12
Integra LifeSciences USD 492.73M 3.63M 2025-12
J&J USD 14.58B 392M 2026-03
Masimo USD 338.6M 20.1M 2025-09
Medtronic USD 6.31B 153M 2025-12
Merit Medical Systems USD 333.7M 7.15M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Solventum Corp USD 1.07B 17M 2025-12
Stryker USD 5.31B 60M 2025-12
Tandem Diabetes Care USD 128.77M 8.51M 2025-12
Teleflex USD 802.46M 108.78M 2025-09
West Pharmaceutical Services USD 452.6M 8.7M 2026-03
Zimmer Biomet Holdings USD 2.25B 39.6M 2026-03